Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

The myxoid liposarcoma FU… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

The myxoid liposarcoma FUS-DDIT3 fusion oncoprotein deregulates NF-kappaB target genes by interaction with NFKBIZ.

Artikel i vetenskaplig tidskrift
Författare Melker Göransson
Mattias K Andersson
C Forni
Anders Ståhlberg
Carola Andersson
A. Olofsson
R Mantovani
Pierre Åman
Publicerad i Oncogene
Volym 28
Nummer/häfte 2
Sidor 270-8
ISSN 1476-5594
Publiceringsår 2009
Publicerad vid Institutionen för neurovetenskap och fysiologi, sektionen för klinisk neurovetenskap och rehabilitering
Institutionen för biomedicin, avdelningen för patologi
Sidor 270-8
Språk en
Länkar dx.doi.org/10.1038/onc.2008.378
Ämnesord Acute-Phase Proteins, biosynthesis, genetics, Binding Sites, CCAAT-Enhancer-Binding Proteins, physiology, Cell Line, Tumor, metabolism, Cell Nucleus, metabolism, ultrastructure, Fibrosarcoma, metabolism, pathology, Humans, Interleukin-6, biosynthesis, genetics, Interleukin-8, biosynthesis, genetics, Lipocalins, biosynthesis, genetics, Liposarcoma, Myxoid, genetics, pathology, NF-kappa B, physiology, Neoplasm Proteins, genetics, physiology, Nuclear Proteins, physiology, Oncogene Proteins, Fusion, genetics, physiology, Promoter Regions, Genetic, genetics, Protein Binding, Protein Interaction Mapping, Proto-Oncogene Proteins, biosynthesis, genetics, RNA-Binding Protein FUS, genetics, physiology, Transcription Factor CHOP, genetics, physiology, Transcription, Genetic
Ämneskategorier Medicin och Hälsovetenskap

Sammanfattning

FUS (also called TLS), EWSR1 and TAF15 (also called TAF2N) are related genes involved in tumor type-specific fusion oncogenes in human malignancies. The FUS-DDIT3 fusion oncogene results from a t(12;16)(q13;p11) chromosome translocation and has a causative role in the initiation of myxoid/round cell liposarcomas (MLS/RCLS). The FUS-DDIT3 protein induces increased expression of the CAAT/enhancer-binding protein (C/EBP) and nuclear factor-kappaB (NF-kappaB)-controlled gene IL8, and the N-terminal FUS part is required for this activation. Chromatin immunoprecipitation analysis showed that FUS-DDIT3 binds the IL8 promoter. Expression studies of the IL8 promoter harboring a C/EBP-NF-kappaB composite site pinpointed the importance of NF-kappaB for IL8 expression in FUS-DDIT3-expressing cells. We therefore probed for possible interaction of FUS-DDIT3 with members of the NF-kappaB family. The nuclear factor NFKBIZ colocalizes with FUS-DDIT3 in nuclear structures, and immunoprecipitation experiments showed that FUS-DDIT3 binds the C-terminal of NFKBIZ. We also report that additional NF-kappaB-controlled genes are upregulated at the mRNA level in FUS-DDIT3-expressing cell lines and they can be induced by NFKBIZ. Taken together, the results indicate that FUS-DDIT3 deregulates some NF-kappaB-controlled genes through interactions with NFKBIZ. Similar mechanisms may be a part of the transformation process in other tumor types carrying FUS, EWSR1 and TAF15 containing fusion oncogenes.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?